Juan C. Jaen, President at Arcus Biosciences, Inc. (RCUS), sold 68,569 shares at $30.05 ($2.0M) on 2026-07-09, disclosed to the SEC on 2026-07-13.
Scheduled sale ($2.0M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.05 | 48,502 | $1.5M | 71.7% |
| 2 | $28.61 | 19,799 | $566K | 27.9% |
| 3 | $29.40 | 268 | $8K | 0.4% |
| Total | $29.63 avg | 68,569 | $2.0M | 100% |
| Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |
| RCUS | SELL | 2025-11-19 | $2.0M | — | Filing → |